Efficacy of noofen use in the treatment of gastroesophageal reflux disease in schoolchildren

Authors

  • S.L. Nyankovskyy Danylo Halytskyi Lviv National Medical University, Lviv, Ukraine
  • M.I. Horodylovska Danylo Halytskyi Lviv National Medical University, Lviv, Ukraine
  • V.A. Ivantsiv Danylo Halytskyi Lviv National Medical University, Lviv, Ukraine
  • O.I. Boyko Lviv Regional Office for Autopsy, Lviv, Ukraine

DOI:

https://doi.org/10.22141/2224-0551.12.2.2017.101405

Keywords:

gastroesophageal reflux disease, autonomic dysfunction, schoolchildren, Noofen

Abstract

We examined 40 children aged 10–18 years, who were diagnosed with gastroesophageal reflux disease (GERD). According to a survey by O.M. Vein, all patients had manifestations of autonomic dysfunction. The children were divided into 2 groups. The control group consisted of 20 patients, who received standard antisecretory therapy. The main group consisted of 20 children, who received standard antisecretory therapy and phenibut (Noofen®, OlainFarm, Latvia) at a dose of 250 mg 2 times a day for 21 days. After 1 month of starting the treatment, an evaluation of its efficacy was conducted. Clinical evaluation of the dynamics of autonomic nervous system status in schoolchildren with GERD suggests that inclusion of Noofen into the complex of therapy for this disease provides good stabilizing effect, which manifests by a restoration of autonomic nervous system balance in schoolchildren.

Downloads

Download data is not yet available.

References

Belousov JV. Gastroesophageal reflux disease in childhood. Eksperimental'naia i klinicheskaia gastroenterologiia. 2011;1:64-70. (in Russian)

Belousov JV. Gastroenterology of childhood. K.: SPD Koljada OP; 2007. 440p. (in Ukrainian)

Volosovec OP. The modern view on the problem of motor function disorders of the upper digestive tract. Zdorov'ye rebenka. 2007;5(114):7-9. (in Ukrainian)

Davydova AN. Specific features of gastroesophageal refluxdisease in school-age children at various autonomic disorders and ways of their correction. Volgograd; 2008. 24p. (in Russian)

Shadrin OG. Pediatric aspects of gastroesophageal reflux disease. Zdorov'ia Ukraіni. 2009;6(1):11. (in Ukrainian)

Zubarenko OV, KravchenkoTJ. The modern view of gastroesophageal reflux disease in children. Perinatolohiya i pedyatriya. 2013;1:114-122. (in Ukrainian)

Belmer SV. Gastroesophageal reflux disease. Rosiiskii meditsinskii zhurnal. 2008;3:144-147. (in Russian)

Sheptulin AA. Gastroesophageal reflux disease: the controversial and unresolved issues. Klinicheskaia meditsina. 2008;6:8-12. (in Russian)

Gold BD. Outcomes of pediatric gastroesophageal reflux disease: in the first year of life, in childhood, and in adults… Oh, and should we really leave Helicobacter pylori alone? J. Pediatr. Gastroenterol. Nutr. 2003;37:S33-S39. doi: 10.1080/026654398364473

Bojarska LM, Ivanova KO. The question of frequency and features of gastroesophageal reflux disease in children. Sovremennaya pediatriya. 2010;2:162-163. (in Ukrainian)

Osyodlo GV. On the state of the autonomic nervous system in the military with various versions of GERD. Mir meditsiny i biologii. 2010;2:146-148. (in Ukrainian)

Abragamovych OO, Leshhuk JL. Features of the autonomic nervous system status in patients with Hp (+) ulcer of the study of heart rate variability and its changes under the influence of complex treatment with AML flurenizydu XII. Acta Medica Leopoliensia. 2007;1–2:59–63. (in Ukrainian)

Іgnashhuk OV,Serkova VK. Effect of treatment with Noofen on the state of the autonomic nervous system in patients with gastroesophageal reflux disease. Medichnі perspektivi. 2010;4:52-56. (in Ukrainian)

Kіshko NY. Correction of vegetative homeostasis in children with gastroesophageal reflux. Pedіatrіia, akusherstvo ta gіnekologіia. 2003;4:17–20. (in Ukrainian)

Nikolaeva OV, SalamehOsama S.A. The functional state of the autonomic nervous system in children with gastroesophageal reflux disease. Vrachebnaia praktika. 2002;2:95–98. (in Russian)

Kuzminova NV, Serkova VK. Autonomic disorders in hypertensive patients: diagnostics and pharmacological correction. Ukraіns'kii terapevtichnii zhurnal. 2009;2(70):37–39. (in Russian)

Published

2021-09-21

How to Cite

Nyankovskyy, S., Horodylovska, M., Ivantsiv, V., & Boyko, O. (2021). Efficacy of noofen use in the treatment of gastroesophageal reflux disease in schoolchildren. CHILD`S HEALTH, 12(2), 211–216. https://doi.org/10.22141/2224-0551.12.2.2017.101405

Issue

Section

Clinical Pediatrics

Most read articles by the same author(s)

1 2 3 > >>